Takeda Development Center Asia, Pte. Ltd. is part of Takeda Pharmaceutical Company Limited, a global biopharmaceutical company focused on research, development, and commercialization of innovative medicines. The Singapore-based development center supports clinical development activities across Asia-Pacific, contributing to global research programs in therapeutic areas such as oncology, gastroenterology, rare diseases, neuroscience, plasma-derived therapies, and vaccines. Its activities include clinical trial management, regulatory coordination, pharmacovigilance support, and collaboration with regional research institutions and healthcare providers. The center plays a strategic role in integrating regional clinical data into Takeda's global development pipeline, ensuring compliance with international regulatory standards and local healthcare frameworks. Strategically, Takeda Development Center Asia focuses on advancing patient-centric innovation, strengthening regional clinical research capabilities, accelerating drug development timelines, and supporting equitable access to breakthrough therapies across Asian markets.
Legal Address
10 Marina Boulevard, #15-01, Marina Bay Financial Centre, Singapore 018983
Singapore; Singapore;
Postal Code: 018983
Contact Details: Purchase the Takeda Development Center Asia, Pte. Ltd. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service